DOJ Seeks Input on Terrorism Victim Reimbursement Form
Published Date: 6/17/2026
Notice
Summary
The Department of Justice is bringing back and updating the application form for the International Terrorism Victim Expense Reimbursement Program. This affects victims of international terrorism who seek help covering their expenses. The DOJ wants your feedback by July 17, 2026, to make sure the form is clear, useful, and easy to fill out—no extra hassle or hidden costs involved!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Reinstated Reimbursement Application Form
The Department of Justice is reinstating and revising the International Terrorism Victim Expense Reimbursement Program application form. It applies to U.S. nationals and U.S. Government employees who are victims of international terrorism that occur outside the United States; the form is voluntary but required if you want to get reimbursement for expenses.
Applicant Time Burden and Limits
The DOJ estimates 51 respondents will complete the form once, spending about 120 minutes each to fill it out, for a total estimated annual burden of 75 hours. The agency seeks Office of Management and Budget approval for this collection for three (3) years and is accepting public comments through July 17, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12143 — Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.
2026-12140 — Importer of Controlled Substances Application: Scottsdale Research Institute
Scottsdale Research Institute wants to become an official importer of some controlled substances like ibogaine and marijuana. People who make or import these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could affect how these substances are brought into the U.S., but no costs or fees are mentioned yet.
2026-12144 — Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.
Previous / Next Documents
Previous: 2026-12212 — Agency Information Collection Activity: Application for Reinstatement (Insurance Lapsed More Than 6 Months) Government Life Insurance and/or Total Disability Income Provision and Application for Reinstatement of Veterans Affairs Life Insurance (VALife) (Insurance Lapsed More than 6 Months)
If your VA life insurance or total disability income coverage lapsed over 6 months ago, you can apply to get it back! The VA is asking for public feedback on the forms used for this process before August 17, 2026. This helps make sure the forms are clear and easy to use, with no extra hassle or cost for veterans.
Next: 2026-12214 — Agency Information Collection Activities: Comment Request; Survey of Graduate Students and Postdoctorates in Science and Engineering
The National Science Foundation wants to keep collecting info about grad students and postdocs in science and engineering for three more years. This survey helps understand who’s studying and working in these fields, and they’re asking the public to share thoughts within 30 days. No big cost changes, just a smooth renewal to keep the data flowing!